Our Program
The Institute for Pediatric Innovation (IPI) and a Consortium of leading pediatric hospitals are collaborating to improve pediatric medical care through development of new products and drug reformulations.
Need and Opportunity
In seeking to provide the highest quality care to their patients, pediatric clinicians and institutions are often limited by available devices or drugs that have not been optimized for the treatment of children. This shortfall in child-appropriate medical devices and drug formulations represents a significant opportunity to effect positive change. IPI addresses this opportunity by creating new methods and pathways to foster, streamline, and stimulate development and commercial adoption of new medical products for children.
Origin of the Concept
IPI has its roots in the Pediatric Product Initiative that CEO Donald Lombardi created when he was Chief Intellectual Property Officer at Children’s Hospital Boston. His aim was to direct innovation toward practical products for unmet clinical needs in pediatric care. He conducted pilot projects to test alternative methods for engaging clinicians in imagining new products and for collaborating with engineering and formulation companies to reduce product concepts to practice. Mr. Lombardi realized that a dedicated entity with a national network would be needed in order to create viable market opportunities. His plan resulted in founding IPI and organizing the Consortium to aggregate clinical requirements, innovation resources, and product concepts across multiple hospitals.
Consortium Contributions and Benefits
The Consortium is a unique collaboration dedicated to innovation and development of practical products designed specifically for treating children. Members of the Consortium contribute the insights of valued clinicians and administrators. Consortium members benefit by participating in funded product development programs, receiving revenue-sharing rewards from products brought to market, gaining public visibility for leadership on this issue, playing a significant role in setting industry priorities, and taking the lead in shaping the design of pediatric products. The resulting new products will improve children’s health while benefiting the clinicians and institutions that use them and the commercial enterprises that provide them.
Programs
|
